Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

4,645 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A nurse-led intervention for carers of people with high-grade glioma: A case series of carers reporting high distress.
Halkett GKB, McDougall E, Berg M, Clarke J, Dhillon HM, Lobb E, Phillips JL, Hudson P, Faris MM, Campbell R, Shaw J, Coyne E, Kelly B, Ownsworth T, Legge DM, Nowak AK. Halkett GKB, et al. Among authors: campbell r. Neurooncol Pract. 2024 Apr 17;11(5):604-616. doi: 10.1093/nop/npae033. eCollection 2024 Oct. Neurooncol Pract. 2024. PMID: 39279774 Free article.
Carer preparedness improved by providing a supportive educational intervention for carers of patients with high-grade glioma: RCT results.
Halkett GKB, Lobb EA, Phillips JL, McDougall E, Clarke J, Campbell R, Dhillon HM, McGeechan K, Hudson P, King A, Wheeler H, Kastelan M, Long A, Nowak AK; Care-IS Project Team. Halkett GKB, et al. Among authors: campbell r. J Neurooncol. 2023 Feb;161(3):501-513. doi: 10.1007/s11060-023-04239-0. Epub 2023 Jan 19. J Neurooncol. 2023. PMID: 36658381 Free PMC article. Clinical Trial.
Unmet needs in people with high-grade glioma: defining criteria for stepped care intervention.
Faris MM, Dhillon HM, Campbell R, Halkett GKB, Miller A, Chan RJ, Haydon HM, Sansom-Daly UM, Koh ES, Ownsworth T, Nowak AK, Kelly B, Leonard R, Pike KE, Legge DM, Pinkham MB, Agar MR; BRAINS Program Group; Shaw J. Faris MM, et al. Among authors: campbell r. JNCI Cancer Spectr. 2024 Jul 1;8(4):pkae034. doi: 10.1093/jncics/pkae034. JNCI Cancer Spectr. 2024. PMID: 38730547 Free PMC article.
Trajectory of Anxiety Related to Radiation Therapy Mask Immobilization and Treatment Delivery in Head and Neck Cancer and Radiation Therapists' Ability to Detect This Anxiety.
Burns M, Campbell R, French S, Dhillon HM, Butow PN, Pritchard A, Sundaresan P. Burns M, et al. Among authors: campbell r. Adv Radiat Oncol. 2022 Apr 18;7(5):100967. doi: 10.1016/j.adro.2022.100967. eCollection 2022 Sep-Oct. Adv Radiat Oncol. 2022. PMID: 36148368 Free PMC article.
Evaluating patient-reported symptoms and late adverse effects following completion of first-line chemotherapy for ovarian cancer using the MOST (Measure of Ovarian Symptoms and Treatment concerns).
Beesley VL, Ross TL, King MT, Campbell R, Nagle CM, Obermair A, Grant P, DeFazio A, Webb PM, Friedlander ML; OPAL Study Group. Beesley VL, et al. Among authors: campbell r. Gynecol Oncol. 2022 Feb;164(2):437-445. doi: 10.1016/j.ygyno.2021.12.006. Epub 2021 Dec 24. Gynecol Oncol. 2022. PMID: 34955238 Free article.
Getting the MOST out of follow-up: a randomized controlled trial comparing 3 monthly nurse led follow-up via telehealth, including monitoring CA125 and patient reported outcomes using the MOST (Measure of Ovarian Symptoms and Treatment concerns) with routine clinic based or telehealth follow-up, after completion of first line chemotherapy in patients with epithelial ovarian cancer.
Cohen PA, Webb PM, King M, Obermair A, Gebski V, Butow P, Morton R, Lawson W, Yates P, Campbell R, Meniawy T, McMullen M, Dean A, Goh J, McNally O, Mileshkin L, Beale P, Beach R, Hill J, Dixon C, Hegarty S, Codde J, Ives A, Lee YC, Brand A, Mellon A, Bilic S, Black I, Jeffares S, Friedlander M. Cohen PA, et al. Among authors: campbell r. Int J Gynecol Cancer. 2022 Apr 4;32(4):560-565. doi: 10.1136/ijgc-2021-002999. Int J Gynecol Cancer. 2022. PMID: 34551895 Clinical Trial.
4,645 results